To assess the efficacy of musta churna on stahulya and its effect on associated inflammatory markers.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Assessment of Obesity based on the Questionnaire
研究概览
简要总结
Excess body fat is the characteristics of obesity, a chronic health risk that is becoming more widespread. It appears gradually and frequently lasts a lifetime. In the United States, obesity is second only to smoking as a preventable cause of mortality. Obesity was formerly thought to be linked to wealthy lifestyles in western nations. Nonetheless, obesity is a rapidly expanding issue in emerging nations and is currently linked to heightened health hazards. Numerous research conducted in India have demonstrated a link between the rising risk of metabolic disorders such type 2 diabetes mellitus, hypertension, and dyslipidaemia with changes in dietary patterns, levels of physical activity, and affluent lifestyles.
Obesity affects people of all ages and genders today. Currently, one-third of people on the planet are obese or overweight. Consequently, the treatment is centred on current global issues. According to a review of the literature, there are many different Ayurvedic anti-obesity formulations in the market, however there aren’t many that balance all the tridoshas and reduce obesity. In order to optimise the formulation for the intended therapeutic impact, minimising the drawbacks of earlier literature in this study. Reducing body weight by limiting the absorption of nutrients is one of the treatment approaches.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)(—)
- 性别
- All
入选标准
- •obese individuals from both the genders in the age group of
- •40 years.
- •BMI greater than or equal to 30 kg/m2 and less than or equal to 34.5 Kg/m2.
排除标准
- •Pathophysiologic/ genetic syndromes associated with obesity (Cushing’s syndrome, Turner’s syndrome, Prader willi syndrome).
- •Patients with poorly controlled Hypertension (greater than 160 / 100 mm Hg)
- •Patients on prolonged (greater than 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, etc.
- •H/o hypersensitivity to any of the trial drugs or their ingredients.
- •Choose the patients who were not enrolled in any study within six (06) months of initial visit.
- •DM, Dyslipidemia, Metabolic Disorder.
结局指标
主要结局
Assessment of Obesity based on the Questionnaire
时间窗: post completion of intervention
次要结局
- assessment of effect on selective biomarkers (inflammatory markers) : IL6, TNF alpha and CRP(90 DAYS)
研究者
VAGHELA AJAYBHAI MANUBHAI
Ayurvedic and Unani Tibbia college and Hospital
